140 related articles for article (PubMed ID: 26341481)
1. Effects of fibroblast growth factor 21 on the heart.
Tanajak P; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2015 Nov; 227(2):R13-30. PubMed ID: 26341481
[TBL] [Abstract][Full Text] [Related]
2. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
[TBL] [Abstract][Full Text] [Related]
4. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.
Planavila A; Redondo I; Hondares E; Vinciguerra M; Munts C; Iglesias R; Gabrielli LA; Sitges M; Giralt M; van Bilsen M; Villarroya F
Nat Commun; 2013; 4():2019. PubMed ID: 23771152
[TBL] [Abstract][Full Text] [Related]
6. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 protects the heart from oxidative stress.
Planavila A; Redondo-Angulo I; Ribas F; Garrabou G; Casademont J; Giralt M; Villarroya F
Cardiovasc Res; 2015 Apr; 106(1):19-31. PubMed ID: 25538153
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1.
Li J; Gong L; Zhang R; Li S; Yu H; Liu Y; Xue Y; Huang D; Xu N; Wang Y; Xu Y; Zhao Y; Li Q; Li M; Li P; Liu M; Zhang Z; Li X; Du W; Wang N
Eur J Pharmacol; 2021 Nov; 910():174470. PubMed ID: 34478691
[TBL] [Abstract][Full Text] [Related]
9. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.
Cheng P; Zhang F; Yu L; Lin X; He L; Li X; Lu X; Yan X; Tan Y; Zhang C
J Diabetes Res; 2016; 2016():1540267. PubMed ID: 27247947
[TBL] [Abstract][Full Text] [Related]
10. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress.
Guo J; Bian Y; Bai R; Li H; Fu M; Xiao C
J Cardiovasc Pharmacol; 2013 Aug; 62(2):143-53. PubMed ID: 23609327
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound‑targeted microbubble destruction technology delivering β‑klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post‑myocardial infarction.
Yue C; Li R; Li C; Yang T; Huang X; Lei R; Yan Y; Liu Y; Li Q; Yan Q; Zuo D; Liu S; Yang M
Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38666537
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 protects against pathological cardiac remodeling by modulating galectin-3 expression.
Sun M; Jin L; Bai Y; Wang L; Zhao S; Ma C; Ma D
J Cell Biochem; 2019 Dec; 120(12):19529-19540. PubMed ID: 31286550
[TBL] [Abstract][Full Text] [Related]
14. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
15. Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection.
Madonna R; Bolli R; Rokosh G; De Caterina R
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):249-53. PubMed ID: 22609872
[TBL] [Abstract][Full Text] [Related]
16. Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury.
Cong WT; Ling J; Tian HS; Ling R; Wang Y; Huang BB; Zhao T; Duan YM; Jin LT; Li XK
Can J Physiol Pharmacol; 2013 Nov; 91(11):973-84. PubMed ID: 24117266
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL
Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545
[TBL] [Abstract][Full Text] [Related]
18. DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism.
Furukawa N; Koitabashi N; Matsui H; Sunaga H; Umbarawan Y; Syamsunarno MRAA; Yamaguchi A; Obokata M; Hanaoka H; Yokoyama T; Kurabayashi M
Heart Vessels; 2021 Jan; 36(1):136-146. PubMed ID: 33073318
[TBL] [Abstract][Full Text] [Related]
19. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
Wang X; Cheng Y; Xue H; Yue Y; Zhang W; Li X
Fitoterapia; 2015 Sep; 105():16-25. PubMed ID: 26025856
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
